// App-Quantinova.ai

153 : Anticoagulants and antiplatelets in COVID-19: impact on survival and thromboembolism development

Researchers

Presenter

  • Thomas Salmon

Principal Investigators

  • Mitchell Titley

  • Zaid Noori

  • Mark Crosby

  • Rajiv Sankaranarayanan

Medical Centers

  • Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Warfarin

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved